1. Bannoehr J, Franco A, Iurescia M, Battisti A, Fitzgerald JR. Molecular diagnostic identification of
Staphylococcus pseudintermedius. J Clin Microbiol. 2009; 47:469–471.
Article
2. Baron F, Cochet MF, Pellerin JL, Ben Zakour N, Lebon A, Navarro A, Proudy I, Le Loir Y, Gautier M. Development of a PCR test to differentiate between
Staphylococcus aureus and
Staphylococcus intermedius. J Food Prot. 2004; 67:2302–2305.
Article
3. Berger-Bächi B, Rohrer S. Factors influencing methicillin resistance in staphylococci. Arch Microbiol. 2002; 178:165–171.
Article
4. Broekema NM, Van TT, Monson TA, Marshall SA, Warshauer DM. Comparison of cefoxitin and oxacillin disk diffusion methods for detection of
mecA-mediated resistance in
Staphylococcus aureus in a large-scale study. J Clin Microbiol. 2009; 47:217–219.
Article
5. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement. CLSI document M100-S20. Wayne: Clinical and Laboratory Standards Institute;2010.
6. Descloux S, Rossano A, Perreten V. Characterization of new staphylococcal cassette chromosome
mec (SCC
mec) and topoisomerase genes in fluoroquinolone- and methicillin-resistant
Staphylococcus pseudintermedius. J Clin Microbiol. 2008; 46:1818–1823.
Article
7. García-Álvarez L, Holden MTM, Lindsay H, Webb CR, Brown DFJ, Curran MD, Walpole E, Brooks K, Pickard DJ, Teale C, Parkhill J, Bentley SD, Edwards GF, Girvan EK, Kearns AM, Pichon B, Hill RLR, Larsen AR, Skov RL, Peacock SJ, Maskell DJ, Holmes MA. Methicillin-resistant
Staphylococcus aureus with a novel
mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis. 2011; 11:595–603.
Article
8. Griffeth GC, Morris DO, Abraham JL, Shofer FS, Rankin SC. Screening for skin carriage of methicillin-resistant coagulase-positive staphylococci and
Staphylococcus schleiferi in dogs with healthy and inflamed skin. Vet Dermatol. 2008; 19:142–149.
Article
9. Ihrke PJ. An overview of bacterial skin disease in the dog. Br Vet J. 1987; 143:112–118.
Article
10. Jones RD, Kania SA, Rohrbach BW, Frank LA, Bemis DA. Prevalence of oxacillin- and multidrug-resistant staphylococci in clinical samples from dogs: 1,772 samples (2001-2005). J Am Vet Med Assoc. 2007; 230:221–227.
Article
11. Khan AU, Sultan A, Tyagi A, Zahoor S, Akram M, Kaur S, Shahid M, Vaishnavi CV. Amplification of
mecA gene in multi-drug resistant
Staphylococcus aureus strains from hospital personnel. J Infect Dev Ctries. 2007; 1:289–295.
Article
12. Kizerwetter-Swida M, Chrobak D, Rzewuska M, Binek M. Antibiotic resistance patterns and occurrence of mecA gene in Staphylococcus intermedius strains of canine origin. Pol J Vet Sci. 2009; 12:9–13.
13. Laurent F, Chardon H, Haenni M, Bes M, Reverdy ME, Madec JY, Lagier E, Vandenesch F, Tristan A. MRSA harboring mecA variant gene mecC, France. Emerg Infect Dis. 2012; 18:1465–1467.
14. Lautz S, Kanbar T, Alber J, Lämmler C, Weiss R, Prenger-Berninghoff E, Zschöck M. Dissemination of the gene encoding exfoliative toxin of
Staphylococcus intermedius among strains isolated from dogs during routine microbiological diagnostics. J Vet Med B Infect Dis Vet Public Health. 2006; 53:434–438.
Article
15. Nishifuji K, Sugai M, Amagai M. Staphylococcal exfoliative toxins: "molecular scissors" of bacteria that attack the cutaneous defense barrier in mammals. J Dermatol Sci. 2008; 49:21–31.
Article
16. Onuma K, Tanabe T, Sato H. Antimicrobial resistance of Staphylococcus pseudintermedius isolates from healthy dogs and dogs affected with pyoderma in Japan. Vet Dermatol. 2012; 23:17–22.
17. Sasaki T, Kikuchi K, Tanaka Y, Takahashi N, Kamata S, Hiramatsu K. Reclassification of phenotypically identified
Staphylococcus intermedius strains. J Clin Microbiol. 2007; 45:2770–2778.
Article
18. Shore AC, Deasy EC, Slickers P, Brennan G, O'Connell B, Monecke S, Ehricht R, Coleman DC. Detection of staphylococcal cassette chromosome
mec type XI carrying highly divergent
mecA,
mecI,
mecR1,
blaZ, and
ccr genes in human clinical isolates of clonal complex 130 methicillin-resistant
Staphylococcus aureus. Antimicrob Agents Chemother. 2011; 55:3765–3773.
Article
19. Skov R, Smyth R, Larsen AR, Bolmstrôm A, Karlsson A, Mills K, Frimodt-Moller N, Kahlmeter G. Phenotypic detection of methicillin resistance in
Staphylococcus aureus by disk diffusion testing and Etest on Mueller-Hinton agar. J Clin Microbiol. 2006; 44:4395–4399.
Article
20. Soedarmanto I, Kanbar T, Ülbegi-Mohyla H, Hijazin M, Alber J, Lämmler C, Akineden Ö, Weiss R, Moritz A, Zschöck M. Genetic relatedness of methicillin-resistant Staphylococcus pseudintermedius (MRSP) isolated from a dog and the dog owner. Res Vet Sci. 2011; 91:e25–e27.
21. Stegmann R, Burnens A, Maranta CA, Perreten V. Human infection associated with methicillin-resistant
Staphylococcus pseudintermedius ST71. J Antimicrob Chemother. 2010; 65:2047–2048.
Article
22. Strommenger B, Kettlitz C, Werner G, Witte W. Multiplex PCR assay for simultaneous detection of nine clinically relevant antibiotic resistance genes in
Staphylococcus aureus. J Clin Microbiol. 2003; 41:4089–4094.
Article
23. Terauchi R, Sato H, Hasegawa T, Yamaguchi T, Aizawa C, Maehara N. Isolation of exfoliative toxin from
Staphylococcus intermedius and its local toxicity in dogs. Vet Microbiol. 2003; 94:19–29.
Article
24. Tolar EL, Hendrix DV, Rohrbach BW, Plummer CE, Brooks DE, Gelatt KN. Evaluation of clinical characteristics and bacterial isolates in dogs with bacterial keratitis: 97 cases (1993-2003). J Am Vet Med Assoc. 2006; 228:80–85.
Article
25. Tomasz A, Drugeon HB, de Lencastre HM, Jabes D, McDougall L, Bille J. New mechanism for methicillin resistance in
Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity. Antimicrob Agents Chemother. 1989; 33:1869–1874.
Article
26. van Duijkeren E, Catry B, Greko C, Moreno MA, Pomba MC, Pyörälä S, Ruzauskas M, Sanders P, Threlfall EJ, Torren-Edo J, Törneke K. Scientific Advisory Group on Antimicrobials (SAGAM). Review on methicillin-resistant Staphylococcus pseudintermedius. J Antimicrob Chemother. 2011; 66:2705–2714.
27. Varges R, Penna B, Martins G, Martins R, Lilenbaum W. Antimicrobial susceptibility of
Staphylococci isolated from naturally occurring canine external ocular diseases. Vet Ophthalmol. 2009; 12:216–220.
Article
28. Wang L, Pan Q, Zhang L, Xue Q, Cui J, Qi C. Investigation of bacterial microorganisms in the conjunctival sac of clinically normal dogs and dogs with ulcerative keratitis in Beijing, China. Vet Ophthalmol. 2008; 11:145–149.
Article
29. Wang Y, Yang J, Logue CM, Liu K, Cao X, Zhang W, Shen J, Wu C. Methicillin-resistant
Staphylococcus pseudintermedius isolated from canine pyoderma in North China. J Appl Microbiol. 2012; 112:623–630.
Article
30. Yoo JH, Yoon JW, Lee SY, Park HM. High prevalence of fluoroquinolone- and methicillin-resistant Staphylococcus pseudintermedius isolates from canine pyoderma and otitis externa in veterinary teaching hospital. J Microbiol Biotechnol. 2010; 20:798–802.
31. Yoon JW, Lee KJ, Lee SY, Chae MJ, Park JK, Yoo JH, Park HM. Antibiotic resistance profiles of Staphylococcus pseudintermedius isolates from canine patients in Korea. J Microbiol Biotechnol. 2010; 20:1764–1768.
32. Zubeir IE, Kanbar T, Alber J, Lämmler C, Akineden O, Weiss R, Zschöck M. Phenotypic and genotypic characteristics of methicillin/oxacillin-resistant
Staphylococcus intermedius isolated from clinical specimens during routine veterinary microbiological examinations. Vet Microbiol. 2007; 121:170–176.
Article